It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Nasopharyngeal carcinoma (NPC) is an invasive cancer with particularly high incidence in Southern China and Southeast Asia. The study of NPC is greatly hampered by the lack of reliable cell lines due to the loss of EBV genome and HeLa cell contamination. Conditional reprogramming (CR) cell culture technique has been reported for rapid and efficient establishment of patient‐derived normal and tumor cell cultures. The purpose of this study was to assess this method to culture NPC patient‐derived primary tumor cells. Using CR protocol, we demonstrated that epithelial cells could be efficiently cultured from normal (70%) and cancerous nasopharyngeal (46%) biopsies. However, by comparing with original tumors in terms of mutation and methylation profiles, epithelial cells derived from cancerous biopsy represented non‐malignant cells. Further, they exhibited stem‐like characteristics based on their cell surface proteins and could differentiate into pseudostratified epithelium in an air–liquid interface culture system. We conclude that CR method is a highly selective and useful method for growing non‐malignant nasopharyngeal epithelial cells.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
2 Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
3 Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
4 Department of Microbiology, Shimane University Faculty of Medicine, Izumo City, Shimane, Japan
5 Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Head & Neck Tumor group, National Cancer Institute of Singapore, Head & Neck Surgery, NUHS, Singapore, Singapore